First-in-Class Selenium-Containing Potent Serotonin Receptor 5-HT<sub>6</sub> Agents with a Beneficial Neuroprotective Profile against Alzheimer’s Disease
作者:Patryk Pyka、Wawrzyniec Haberek、Małgorzata Więcek、Ewa Szymanska、Wesam Ali、Agnieszka Cios、Magdalena Jastrzębska-Więsek、Grzegorz Satała、Sabina Podlewska、Silvia Di Giacomo、Antonella Di Sotto、Sabrina Garbo、Tadeusz Karcz、Chiara Lambona、Francesco Marocco、Gniewomir Latacz、Sylwia Sudoł-Tałaj、Barbara Mordyl、Monika Głuch-Lutwin、Agata Siwek、Kinga Czarnota-Łydka、Dawid Gogola、Agnieszka Olejarz-Maciej、Natalia Wilczyńska-Zawal、Ewelina Honkisz-Orzechowska、Małgorzata Starek、Monika Dąbrowska、Katarzyna Kucwaj-Brysz、Rossella Fioravanti、Muhammad Jawad Nasim、Marius Hittinger、Anna Partyka、Anna Wesołowska、Cecilia Battistelli、Clemens Zwergel、Jadwiga Handzlik
DOI:10.1021/acs.jmedchem.3c02148
日期:2024.1.25
Recently, the serotonin receptor 5-HT6 emerged as a promising target for AD treatment; thus, here a new series of 5-HT6R ligands with a 1,3,5-triazine core and selenoether linkers was explored. Among them, the 2-naphthyl derivatives exhibited strong 5-HT6R affinity and selectivity over 5-HT1AR (13–15), 5-HT7R (14 and 15), and 5-HT2AR (13). Compound 15 displayed high selectivity for 5-HT6R over other
阿尔茨海默病 (AD) 的病因复杂且尚不完全清楚。最近,血清素受体 5-HT6 成为 AD 治疗的有前途的靶点;因此,这里探索了一系列具有 1,3,5-三嗪核心和硒醚接头的新 5-HT6R 配体。其中,2-萘基衍生物对 5-HT1AR (13–15)、5-HT7R (14 和 15) 和 5-HT2AR (13) 表现出较强的 5-HT6R 亲和力和选择性。化合物 15 对 5-HT6R 的选择性高于其他中枢神经系统受体,并且表现出低心脏、肝脏和肾毒性风险,并且无致突变性,表明其“类药”潜力。化合物 15 还显示出对鱼藤酮诱导的神经毒性的神经保护作用,以及抗氧化剂和谷胱甘肽过氧化物酶 (GPx) 样活性,并调节抗氧化和促炎基因以及 NRF2 核易位。在大鼠中,15 种表现出令人满意的药代动力学,穿透血脑屏障,逆转 MK-801 诱导的记忆障碍,并表现出抗焦虑样特性。15 的神经保护和认知样